You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
23 October 2024 - Biotechnology company Virax Biolabs Group Limited (NASDAQ: VRAX) on Wednesday announced a new distribution agreement with Europa Biosite for the commercialisation of its ImmuneSelect Research Use portfolio in the United Kingdom and ...
23 October 2024 - Repare Therapeutics Inc (Nasdaq: RPTX), a clinical-stage precision oncology firm, announced on Wednesday that it has reported updated safety and tolerability results from its Phase 1 MYTHIC clinical trial. The trial evaluates the co...
23 October 2024 - Public benefit corporation United Therapeutics Corporation (Nasdaq: UTHR) and its subsidiary Lung Bioengineering Inc (LBE) announced on Wednesday that they have achieved a significant milestone, completing the 500th lung transplant ...
23 October 2024 - Bicycle Therapeutics (NASDAQ: BCYC) announced on Wednesday that it presented its first human imaging data at the EANM 2024 Congress, confirming the potential of MT1-MMP as a new target for cancer treatment. Data validated the effect...
23 October 2024 - JCR Pharmaceuticals Co, Ltd (TSE 4552) presented promising preclinical data on its adeno-associated virus (AAV) gene therapy research at the European Society of Gene and Cell Therapy's 31st Annual Congress in Rome, held from 22...
23 October 2024 - Space infrastructure company Redwire Corporation (NYSE: RDW) on Wednesday announced a collaboration with biopharmaceutical company Bristol Myers Squibb (BMS) to study small molecule drug compounds aboard the International Space Stat...
23 October 2024 - Medical technology company AngioDynamics Inc (NASDAQ:ANGO) announced on Wednesday that it has initiated a global study to assess the long-term effects of its NanoKnife System in treating prostate cancer.Conducted in partnership with...